Overview

• Eli Lilly told UK wholesalers to stop taking Mounjaro orders until 1 September, when a list‑price increase of up to 170% takes effect.
• Confidential documents seen by Sky News show a rebate scheme that would lower the top 15mg dose to £247.50 a month, an £83 saving on the new £330 list price.
• Major chains including Boots, Lloyds Pharmacy and Superdrug reported shortages or restricted supply, with many providers prioritising existing patients and limiting new starts.
• Demand has shifted to alternative GLP‑1 drugs, with one supplier reporting Wegovy sales up roughly 2,600% after the price announcement.
• Pharmacy bodies and regulators cautioned against turning to unregulated sellers and unsafe dosing changes, while Lilly said NHS patients are protected by separate arrangements.